These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 26400999)

  • 1. CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection.
    Freeman ML; Mudd JC; Shive CL; Younes SA; Panigrahi S; Sieg SF; Lee SA; Hunt PW; Calabrese LH; Gianella S; Rodriguez B; Lederman MM
    Clin Infect Dis; 2016 Feb; 62(3):392-6. PubMed ID: 26400999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy.
    Christensen-Quick A; Massanella M; Frick A; Rawlings SA; Spina C; Vargas-Meneses M; Schrier R; Nakazawa M; Anderson C; Gianella S
    J Virol; 2019 Jul; 93(13):. PubMed ID: 31019052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proximity of Cytomegalovirus-Specific CD8
    Heath JJ; Fudge NJ; Gallant ME; Grant MD
    Front Immunol; 2018; 9():201. PubMed ID: 29527205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of antiretroviral and tuberculosis therapies on CD4
    Chiacchio T; Petruccioli E; Vanini V; Cuzzi G; La Manna MP; Orlando V; Pinnetti C; Sampaolesi A; Antinori A; Caccamo N; Goletti D
    Immunol Lett; 2018 Jun; 198():33-43. PubMed ID: 29635002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymptomatic CMV Replication During Early Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower CD4/CD8 Ratio During HIV Treatment.
    Smith DM; Nakazawa M; Freeman ML; Anderson CM; Oliveira MF; Little SJ; Gianella S
    Clin Infect Dis; 2016 Dec; 63(11):1517-1524. PubMed ID: 27601222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Aging, Cytomegalovirus Infection, and Long-Term Treatment for Human Immunodeficiency Virus on CD8
    Veel E; Westera L; van Gent R; Bont L; Otto S; Ruijsink B; Rabouw HH; Mudrikova T; Wensing A; Hoepelman AIM; Borghans JAM; Tesselaar K
    Front Immunol; 2018; 9():572. PubMed ID: 29619031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus-specific T-cells are associated with immune senescence, but not with systemic inflammation, in people living with HIV.
    Ballegaard V; Brændstrup P; Pedersen KK; Kirkby N; Stryhn A; Ryder LP; Gerstoft J; Nielsen SD
    Sci Rep; 2018 Feb; 8(1):3778. PubMed ID: 29491459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts.
    Cao W; Mehraj V; Trottier B; Baril JG; Leblanc R; Lebouche B; Cox J; Tremblay C; Lu W; Singer J; Li T; Routy JP; ; Vézina S; Charest L; Milne M; Huchet E; Lavoie S; Friedman J; Duchastel M; Villielm F; Côté P; Potter M; Lessard B; Charron MA; Dufresne S; Turgeon ME; Rouleau D; Labrecque L; Fortin C; de Pokomandy A; Hal-Gagné V; Munoz M; Deligne B; Martel-Laferrière V; Gilmore N; Fletcher M; Szabo J
    Clin Infect Dis; 2016 Jan; 62(2):250-257. PubMed ID: 26349551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery.
    Gómez-Mora E; Massanella M; García E; Giles D; Bernadó M; Urrea V; Carrillo J; Ouchi D; Puig J; Negredo E; Clotet B; Blanco J; Cabrera C
    PLoS One; 2017; 12(9):e0184433. PubMed ID: 28934217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of transforming growth factor beta 1 in non-progressive HIV-1 infection correlates with markers of disease progression.
    Maina EK; Abana CZ; Bukusi EA; Sedegah M; Lartey M; Ampofo WK
    Cytokine; 2016 May; 81():109-16. PubMed ID: 26986868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
    Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
    AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High CMV IgG antibody levels are associated to a lower CD4+ RESPONSE to antiretroviral therapy in HIV-infected women.
    Giuliano M; Pirillo MF; Liotta G; Andreotti M; Jere H; Sagno JB; Ciccacci F; Amici R; Marazzi MC; Vella S; Palombi L; Mancinelli S
    J Clin Virol; 2017 Nov; 96():17-19. PubMed ID: 28918126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses.
    Hsue PY; Hunt PW; Sinclair E; Bredt B; Franklin A; Killian M; Hoh R; Martin JN; McCune JM; Waters DD; Deeks SG
    AIDS; 2006 Nov; 20(18):2275-83. PubMed ID: 17117013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief Report: Soluble CD163 in CMV-Infected and CMV-Uninfected Subjects on Virologically Suppressive Antiretroviral Therapy in the ICONA Cohort.
    Vita S; Lichtner M; Marchetti G; Mascia C; Merlini E; Cicconi P; Vullo V; Viale P; Costantini A; DʼArminio Monforte A;
    J Acquir Immune Defic Syndr; 2017 Mar; 74(3):347-352. PubMed ID: 27828874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4
    Gómez-Mora E; García E; Urrea V; Massanella M; Puig J; Negredo E; Clotet B; Blanco J; Cabrera C
    Sci Rep; 2017 Sep; 7(1):11711. PubMed ID: 28916780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects.
    Komanduri KV; Donahoe SM; Moretto WJ; Schmidt DK; Gillespie G; Ogg GS; Roederer M; Nixon DF; McCune JM
    Virology; 2001 Jan; 279(2):459-70. PubMed ID: 11162802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ T Cell Recovery and Hepatitis B Virus Coinfection in HIV-Infected Patients from Côte d'Ivoire Initiating Antiretroviral Therapy.
    Houghtaling L; Moh R; Abdou Chekaraou M; Gabillard D; Anglaret X; Eholié SP; Zoulim F; Danel C; Lacombe K; Boyd A
    AIDS Res Hum Retroviruses; 2018 May; 34(5):439-445. PubMed ID: 29466862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection.
    Eggena MP; Barugahare B; Okello M; Mutyala S; Jones N; Ma Y; Kityo C; Mugyenyi P; Cao H
    J Infect Dis; 2005 Mar; 191(5):694-701. PubMed ID: 15688282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune resilience in HIV-infected individuals seronegative for cytomegalovirus.
    Barrett L; Stapleton SN; Fudge NJ; Grant MD
    AIDS; 2014 Sep; 28(14):2045-9. PubMed ID: 25265072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.